Creative Biolabs provides high quality products and services to the global biology researcher at inception as their lofty mission. After more than ten years of innovation and development, we have grown into a prestigious CRO in the industry. In addition to providing researchers with various products such as recombinant proteins, antibodies, and test kits, we have also accumulated a lot of experience in drug discovery and vaccine development. Especially in the field of antiviral drugs and vaccines, our drug discovery, vaccine design, preclinical evaluation of drugs and vaccines, and in vitro diagnostic services are at the world-leading level. Recombinant ARHGDIA Protein Human origin https://sars-cov-2.creative-biolabs.com/recombinant-arhgdia-protein-human-origin-1504.htm

The 2019 novel coronavirus, or "SARS-CoV-2", was discovered because of Wuhan virus pneumonia cases in 2019, and was named by the World Health Organization on January 12, 2020. It belongs to the beta genera of the Coronaviridae family, together with SARS coronavirus in 2003 and MERS coronavirus in 2012. The alignment between SARS-CoV-2 and 2003 SARS CoV has about 70% sequence similarity and 40% sequence similarity with MERS CoV. Anti-C3 Polyclonal https://sars-cov-2.creative-biolabs.com/target-sars-cov-2-191.htm

Creative Biolabs is dedicated to the development of small molecule PROTACs and we offer our clients with all aspects to best fit your needs to maximally promote the project progression. With advanced platform and senior scientists, we are committed to exploring and offering highly tailored ligands to fit your timeline and research budget. For more details regarding Creative Biolab's PROTAC service and a detailed quote, please feel free to contact us to assist you. E3 ubiquitin ligase https://www.creative-biolabs.com/protac/ligand-screening-for-e3-ligase.htm

Phage-based detection assays are based on the selectivity of phages for specific bacterial target. In these assay, phages act as important bio-recognition elements. Excellent expert staff at Creative Biolabs have established a proprietary phage-based pathogen detection platform. Leveraging this versatile platform, we provide a broad range of solutions for bacterial pathogen detection, concerning many fields including food safety and clinical diagnosis. phage based detection https://phagenbio.creative-biolabs.com/phage-based-bacterial-pathogen-detection.htm

Compared to traditional vaccine, phage display vaccines have several advantages, such as higher stability and security, short production cycle and high yield. Aided by our excellent technical platform and accumulated experience, Creative Biolabs provides phage-displayed vaccine development services for global customers. We make a promise that the generated phage-displayed vaccines possess the ability of inducing appropriate immune response to meet scientific and clinical purposes. phage displayed vaccines https://phagenbio.creative-biolabs.com/development-of-phage-displayed-vaccines.htm

Oncolytic viruses (OVs) is a group of viruses that selectively replicate in and kill cancer cells, while leaving the normal tissue uninfected. In addition to direct oncolysis activity, OVs are also very effective at inducing immune responses against tumor cells. OVs encompass a broad diversity of DNA and RNA viruses that are naturally cancer-selective or can be genetically-engineered. SV40-EGFP https://www.creative-biolabs.com/oncolytic-virus/reporter-encoding-oncolytic-herpes-simplex-virus-1-icp27-sv40-egfp-92.htm

At present, antibody-drug conjugates (ADCs) represent a promising therapeutic strategy for cancer by combining the antigen-targeting specificity of monoclonal antibodies (mAbs) with the cytotoxic potency of chemotherapeutic drugs. As a well-recognized leader in antibody production and development with over a decade of experience, Creative Biolabs is dedicated to the discovery of new therapeutic agents against various diseases. Here, we offer our clients with comprehensive high-quality non-IgG antibody ADCs (NADCs) services to promote the disease diagnosis and treatment. Non-IgG Antibody Drug Conjugates https://non-igg-ab.creative-biolabs.com/non-igg-antibody-drug-conjugates-service.htm

Creative Biolabs is a professional non-IgG therapeutic antibody development expert with extensive experience in antibody design, immunogenicity evaluation, safety evaluation, and production process optimization. We have won a good reputation among our worldwide customers for successfully accomplishing numerous challenging projects in IgA antibody development. Here, we provide a number of premade IgA monoclonal and polyclonal antibodies with high purity and quality. If the IgA antibodies you need are not in our list, we also provide customization services for your specific antibody products. Please directly contact us or send us an inquiry for more detailed information. IgA Antibodies Products https://non-igg-ab.creative-biolabs.com/category-iga-342.htm

With unrivaled expertise and experiences in epigenomics services, Creative Biolabs independently developed a novel targeted methylation sequencing platform to analyze the DNA methylation for the target regions of interest. As expert in DNA methylation analysis, our scientists are dedicated to one-stop solutions from sample preparation to data analysis to meet your specific requirements and budgets. DNA methylation sequencing https://www.creative-biolabs.com/suprecision/targeted-methylation-sequencing-service.htm

Tumor tissues and cells are valuable materials for studying the pathological mechanism of a tumor and discovering novel drug targets for tumor treatment. Creative Biolabs is a world-leading service provider in the field of cancer research using NGS technology. We provide a full range of solutions for cancer research involved in the development of cancer 3D model, NGS for cancer 3D model, and therapeutic validation in the cancer 3D model. Our clients will benefit from our superior end-to-end services and the most comprehensive technical guidance from a professional expert team. 3D model services for tumour https://www.creative-biolabs.com/suprecision/one-stop-service-for-cancer-3d-model.htm

Our cutting-edge hybridoma development and phage display platforms allow the production of the most comprehensive list of recombinant antibody products and extensive service portfolio at the most competitive price. Our products range from antibody / peptide libraries, Biosimilar cell lines, Chimeric antigen receptor (CAR) products, antibody-drug conjugates (ADCs) to engineered antibodies such as therapeutic antibodies, single-domain antibodies, bispecific antibodies and intrabodies. We also provide professional custom antibody discovery and engineering services, featuring phage display library construction, antibody humanization, chimerization, engineered antibody production (Fab, scFc, tribody, bispecific antibody, SdAb, minibody, etc.), antibody labeling, hybridoma/stable cell line development, membrane protein production and cGMP-manufacturing which enable larger scale antibody production for development of animal-based assays and clinical trials. NS5 Tetramer https://www.creativebiolabs.net/symbolsearch_NS5_62.htm

Our cutting-edge hybridoma development and phage display platforms allow the production of the most comprehensive list of recombinant antibody products and extensive service portfolio at the most competitive price. Our products range from antibody / peptide libraries, Biosimilar cell lines, Chimeric antigen receptor (CAR) products, antibody-drug conjugates (ADCs) to engineered antibodies such as therapeutic antibodies, single-domain antibodies, bispecific antibodies and intrabodies. We also provide professional custom antibody discovery and engineering services, featuring phage display library construction, antibody humanization, chimerization, engineered antibody production (Fab, scFc, tribody, bispecific antibody, SdAb, minibody, etc.), antibody labeling, hybridoma/stable cell line development, membrane protein production and cGMP-manufacturing which enable larger scale antibody production for development of animal-based assays and clinical trials. fab antibody https://www.creativebiolabs.net/fab-fragment-antibodies_24.htm

Amyotrophic lateral sclerosis (ALS) is a kind of natural autoantibodies (NAA)-related neurological disease that is mainly presented as muscular paralysis. Over the past years, we Creative Biolabs has committed to the researches of natural autoantibodies and related diseases. Based on our innovate and advanced technology platform, we can provide professional strategies and improved NAA services on ALS for our customers throughout the world. amyotrophic lateral sclerosis https://www.creative-biolabs.com/natural-autoantibody/amyotrophic-lateral-sclerosis-als.htm

During developments of mRNA therapeutics, the stability and translation efficiency remains two pivotal issues at early stage and may have influences throughout the overall development processes even the large scale manufacture and they need to be addressed as early as possible. To this end, Creative Biolabs has developed a comprehensive platform enabling optimization of mRNA synthesis, modification, and delivery method. Cytokine mRNA https://mrna.creative-biolabs.com/category-cytokine-mrna-455.htm

During developments of mRNA therapeutics, the stability and translation efficiency remains two pivotal issues at early stage and may have influences throughout the overall development processes even the large scale manufacture and they need to be addressed as early as possible. To this end, Creative Biolabs has developed a comprehensive platform enabling optimization of mRNA synthesis, modification, and delivery method. Support of mRNA Research https://mrna.creative-biolabs.com/technology.htm

Creative Biolabs was established as a biotechnology company specializing in developing and production of antibodies and also a service provider for customized products and relevant services. The company was founded by a group of scientists and entrepreneurs who are committed to changing the traditional antibody model and establishing a new service platform. Employees at Creative Biolabs are composed of elites (Masters & PhD) from top universities worldwide. As an antibody customization service provider, we are dedicated to the research and development of antibodies to animals, plants and microorganisms, focusing on the research needs of different models of biological antibodies and becoming a direct supplier of products. anti znrf3 antibody https://modelorg-ab.creative-biolabs.com/symbol-znrf3-73502.htm

Creative Biolabs was established as a biotechnology company specializing in developing and production of antibodies and also a service provider for customized products and relevant services. The company was founded by a group of scientists and entrepreneurs who are committed to changing the traditional antibody model and establishing a new service platform. Employees at Creative Biolabs are composed of elites (Masters & PhD) from top universities worldwide. As an antibody customization service provider, we are dedicated to the research and development of antibodies to animals, plants and microorganisms, focusing on the research needs of different models of biological antibodies and becoming a direct supplier of products. anti xrcc2 antibody https://modelorg-ab.creative-biolabs.com/symbol-xrcc2-32326.htm

The microfluidic technology developed in the early 1990s initially studied and manipulated liquid transport rules on the micrometer and nanometer scales. With the continuous development of this technology, microfluidic technology is widely used in life science and medical research and has achieved remarkable results. Creative Biolabs combines its rich biomedical research experience with microfluidic technology to provide customers with microfluidic chip design and customization services for specific needs. microfluidic for digestive juices analysis https://microfluidics.creative-biolabs.com/other-biological-fluids-analysis-on-microfluidic-chips.htm

As a leading custom service provider, Creative Biolabs has devoted to the development of microfluidic technology for many years. By advanced microfluidic technology platform, we can offer a full package of microfluidics integrated solutions for multiple applications. microfluidics-based analysis in pathogen detection https://microfluidics.creative-biolabs.com/microfluidics-based-analysis-in-pathogen-detection.htm

Clostridium is the primary obligate anaerobe investigated as an anticancer agent. In the last decade, there has been significant progress in the development and refinement of strategies based on tumor colonization using a range of Clostridium species. Based on our extensive experience, Creative Biolabs provides Clostridium acetobutylicum based drug development for our customers all over the world. clostridia probiotic https://live-biotherapeutic.creative-biolabs.com/clostridium-acetobutylicum.htm

Live biotherapeutics, a new class of medicines, is used for the prevention, treatment, or cure of many diseases such as skin diseases, gastrointestinal disease. During the development of live biotherapeutics, it is essential to test carbohydrate fermentative profiles, which is useful for the identification and classification of candidate live bacteria. Creative Biolabs leverages a proficient carbohydrate fermentation test technology to support the development of live biotherapeutics. Carbohydrate Fermentative Profiles for Live Biotherapeutic Products https://live-biotherapeutic.creative-biolabs.com/carbohydrate-fermentative-profiles-for-live-biotherapeutic-products.htm

Creative Biolabs is one of the few companies who can offer integrated drug discovery services for clients all over the world. Talented and well-trained scientists are working closely with each other to realize the goal of our customers. To discover and develop the qualified medicines of tomorrow, our scientists are concentrating on every important aspect of the industry, especially for the drug discovery pipeline. Our services range from target identification and validation, hit identification, hit to lead, lead optimization to the investigational new drug (IND), and are subdivided into numerous details. Our dedicated scientists are able to undertake the entire discovery pipeline but also pleased to offer specific service based on clients’ requirements. Creative Biolabs is adhering the customer first and goal-oriented concept to serve our global clients with the most reliable and qualified results. er marker https://www.creative-biolabs.com/drug-discovery/diagnostics/ivd-antibody-development-services-for-er-marker.htm

Creative Biolabs is one of the few companies who can offer integrated drug discovery services for clients all over the world. Talented and well-trained scientists are working closely with each other to realize the goal of our customers. To discover and develop the qualified medicines of tomorrow, our scientists are concentrating on every important aspect of the industry, especially for the drug discovery pipeline. Our services range from target identification and validation, hit identification, hit to lead, lead optimization to the investigational new drug (IND), and are subdivided into numerous details. Our dedicated scientists are able to undertake the entire discovery pipeline but also pleased to offer specific service based on clients’ requirements. Creative Biolabs is adhering the customer first and goal-oriented concept to serve our global clients with the most reliable and qualified results. d dimer marker https://www.creative-biolabs.com/drug-discovery/diagnostics/ivd-antibody-development-services-for-d-dimer-marker.htm

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow treating a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery. There are numerous ongoing researches of which the focus is testing several approaches to gene therapy. Although gene therapy is a promising treatment scenario for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections, there is still a number of obstacles to be overcome in terms of the therapeutic modality selection and design at the very early stage of development, design and application of in vitro and in vivo assays for proof-of-concept studies, comprehensive development of full set of assays for measuring potency and safety, from which the information should be clarified to support an Investigational New Drug Application (IND) or a Biologics License Application (BLA). C14orf70 pU6 shRNA https://www.creative-biolabs.com/gene-therapy/raav-2-pu6-c14orf70-shrna-seq1-488.htm

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow treating a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery. There are numerous ongoing researches of which the focus is testing several approaches to gene therapy. Although gene therapy is a promising treatment scenario for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections, there is still a number of obstacles to be overcome in terms of the therapeutic modality selection and design at the very early stage of development, design and application of in vitro and in vivo assays for proof-of-concept studies, comprehensive development of full set of assays for measuring potency and safety, from which the information should be clarified to support an Investigational New Drug Application (IND) or a Biologics License Application (BLA). ZNF280C pU6 shRNA https://www.creative-biolabs.com/gene-therapy/raav-2-pu6-znf280c-shrna-seq1-443.htm

Alfa Chemistry offers an extensive catalog of materials in a wide range of applications. Products listed on our website are either in stock or can be resynthesized within a reasonable time frame. In stock products can be shipped out within 3-5 business days upon receipt of customers' purchase order. Poly(dimethylsiloxane), monohydroxy terminated https://materials.alfachemic.com/product/poly-dimethylsiloxane-monohydroxy-terminated-295436.html